What is the main purpose of Supplemental Indenture No. 17?

The main purpose of Supplemental Indenture No. 17 is to amend the conditions under which HCA can release collateral and subsidiary guarantees related to its first lien secured notes. It tightens the requirements for what constitutes an "Investment Grade Rating Event".

How does this change affect the release of HCA's collateral?

Previously, an investment grade rating on the first lien secured notes might have been sufficient to trigger the release of collateral. Now, an investment grade rating on the "corporate family rating" of HCA Holdings and its subsidiaries is also required, making the release of collateral more difficult to achieve.

Why is this information important for investors?

This amendment is important for investors as it impacts HCA's financial flexibility and its ability to reduce its debt obligations by releasing collateral. Investors should be aware that achieving an investment grade rating solely on the notes may not be enough to trigger collateral release, and the company's overall credit profile needs to meet this higher standard.

Does this filing indicate any immediate financial distress or changes in HCA's debt?

No, this filing does not indicate immediate financial distress. It is a proactive amendment to debt covenants that modifies future conditions for collateral release based on credit ratings. It does not change the existing debt structure or terms, but rather the criteria for specific covenant relaxations.

HCA 8-K: Material Agreements

Summary

HCA Holdings, Inc. (HCA) filed an 8-K on December 9, 2016, to report on a material definitive agreement. Specifically, the company entered into Supplemental Indenture No. 17, which amends provisions related to the release of collateral and subsidiary guarantees for its first lien secured notes. This amendment adjusts the definition of an "Investment Grade Rating Event" to necessitate an investment grade rating for the "corporate family rating" of HCA Holdings and its subsidiaries, in addition to the notes themselves, before such collateral and guarantees can be released. This filing is significant for investors as it alters the conditions under which HCA can de-lever its balance sheet by releasing collateral. The stricter criteria, requiring a broader corporate family rating to be investment grade, means that the release of collateral and guarantees may be delayed or may not occur even if the secured notes themselves achieve an investment grade rating. Investors should monitor HCA's corporate credit ratings and its financial performance as it pertains to achieving this broader investment grade status.

Key Highlights

1HCA Holdings entered into Supplemental Indenture No. 17 on December 9, 2016.
2The supplemental indenture amends provisions related to the release of collateral and subsidiary guarantees on certain first lien secured notes.
3The definition of an "Investment Grade Rating Event" has been modified.
4The new definition requires an investment grade rating for the "corporate family rating" (or comparable designation) of Holdings and its subsidiaries.
5This requirement is in addition to an investment grade rating for the first lien secured notes themselves.
6The amendment imposes stricter conditions for releasing collateral and subsidiary guarantees.

HCA Healthcare, Inc. 8-K Report, Material Agreement (Dec 9, 2016)

Summary

Key Highlights

Frequently Asked Questions